Jhon Prieto

837 total citations
22 papers, 510 citations indexed

About

Jhon Prieto is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Jhon Prieto has authored 22 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 10 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in Jhon Prieto's work include Liver Disease Diagnosis and Treatment (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Liver Disease and Transplantation (4 papers). Jhon Prieto is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Liver Disease and Transplantation (4 papers). Jhon Prieto collaborates with scholars based in United States, Spain and Ecuador. Jhon Prieto's co-authors include Michael A. Barry, Sheila Sherlock, Domingo Balderramo, Ângelo Zambam de Mattos, José D. Debes, André Boonstra, Marco Arrese, Miquel Navasa, Pablo A. Romagnoli and Andrés Cárdenas and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Journal of Hepatology.

In The Last Decade

Jhon Prieto

20 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jhon Prieto United States 10 181 159 140 115 74 22 510
Pietro Solero Italy 8 170 0.9× 213 1.3× 267 1.9× 83 0.7× 29 0.4× 9 621
Michael Sorell United States 9 180 1.0× 163 1.0× 84 0.6× 40 0.3× 50 0.7× 12 598
Nigel Heaton United Kingdom 14 52 0.3× 229 1.4× 299 2.1× 64 0.6× 13 0.2× 29 559
Dario Tavazzi Italy 14 257 1.4× 164 1.0× 54 0.4× 272 2.4× 77 1.0× 36 718
Harald E. Fischer United States 11 185 1.0× 85 0.5× 62 0.4× 29 0.3× 9 0.1× 21 435
M Bouvier United States 11 427 2.4× 52 0.3× 19 0.1× 67 0.6× 38 0.5× 29 688
Norio Itokawa Japan 15 28 0.2× 336 2.1× 290 2.1× 16 0.1× 34 0.5× 54 519
Anne McCune United Kingdom 13 62 0.3× 380 2.4× 226 1.6× 48 0.4× 52 0.7× 23 606
A Musca Italy 13 45 0.2× 223 1.4× 230 1.6× 22 0.2× 25 0.3× 34 466
Faisal Saud Dar Pakistan 14 27 0.1× 150 0.9× 301 2.1× 17 0.1× 22 0.3× 64 535

Countries citing papers authored by Jhon Prieto

Since Specialization
Citations

This map shows the geographic impact of Jhon Prieto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jhon Prieto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jhon Prieto more than expected).

Fields of papers citing papers by Jhon Prieto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jhon Prieto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jhon Prieto. The network helps show where Jhon Prieto may publish in the future.

Co-authorship network of co-authors of Jhon Prieto

This figure shows the co-authorship network connecting the top 25 collaborators of Jhon Prieto. A scholar is included among the top collaborators of Jhon Prieto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jhon Prieto. Jhon Prieto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Prieto, Jhon, Ângelo Zambam de Mattos, Ângelo Alves de Mattos, et al.. (2023). Epidemiology and risk factors for histopathologic characteristics of non‐alcoholic fatty liver disease in South America. Alimentary Pharmacology & Therapeutics. 58(5). 526–536. 1 indexed citations
2.
Fu, Siyu, Jhon Prieto, Domingo Balderramo, et al.. (2023). Assessment of TLL1 variant and risk of hepatocellular carcinoma in Latin Americans and Europeans. Annals of Hepatology. 29(2). 101181–101181. 3 indexed citations
3.
Prieto, Jhon, Domingo Balderramo, Ângelo Zambam de Mattos, et al.. (2023). MBOAT7 rs641738 Variant Is Not Associated with an Increased Risk of Hepatocellular Carcinoma in a Latin American Cohort. Digestive Diseases and Sciences. 68(11). 4212–4220. 3 indexed citations
4.
Anugwom, Chimaobi M., Jhon Prieto, Domingo Balderramo, et al.. (2023). Assessment of STAT4 Variants and Risk of Hepatocellular Carcinoma in Latin Americans and Europeans. Cancers. 15(18). 4530–4530. 2 indexed citations
5.
Anugwom, Chimaobi M., Ângelo Zambam de Mattos, Marco Arrese, et al.. (2022). Changing epidemiology of hepatocellular carcinoma in South America: A report from the South American liver research network. Annals of Hepatology. 28(2). 100876–100876. 20 indexed citations
6.
Debes, José D., Pablo A. Romagnoli, Jhon Prieto, et al.. (2021). Serum Biomarkers for the Prediction of Hepatocellular Carcinoma. Cancers. 13(7). 1681–1681. 57 indexed citations
7.
Balderramo, Domingo, Ângelo Zambam de Mattos, Denusa Wiltgen, et al.. (2021). Abnormal Liver Tests during Hospitalization Predict Mortality in Patients with COVID‐19: A Multicenter Study from South America. Canadian Journal of Gastroenterology and Hepatology. 2021(1). 1622533–1622533. 9 indexed citations
8.
Debes, José D., Enrique Carrera, Ângelo Zambam de Mattos, Jhon Prieto, & André Boonstra. (2019). Hepatocellular carcinoma, a unique tumor with a lack of biomarkers. Annals of Hepatology. 18(6). 786–787. 12 indexed citations
9.
Prieto, Jhon, et al.. (2019). Acalasia, una visión actual. SHILAP Revista de lepidopterología. 34(2). 171–178. 1 indexed citations
10.
Menéndez, J. Carlos, et al.. (2018). Risk Factors of Mortality After Liver Transplantation in Uruguay. Transplantation Proceedings. 50(2). 499–502. 5 indexed citations
11.
Ruiz, Juan, et al.. (2017). Gene therapy of viral hepatitis and hepatocellular carcinoma. Revista de medicina de la Universidad de Navarra. 64–64.
12.
Mendoza, Yuly P., et al.. (2015). Guía de práctica clínica para la enfermedad hepática grasa no alcohólica. Revista Colombiana de Gastroenterología. 30(1). 89–96. 3 indexed citations
13.
Mendoza, Yuly P., et al.. (2015). Guía de práctica clínica para la enfermedad hepática grasa no alcohólica Clinical practice guideline for nonalcoholic fatty liver disease. 1 indexed citations
14.
Prieto, Jhon, Marina Berenguer, Manuel de la Mata, et al.. (2012). Control of Blood Pressure in Liver Transplant Recipients. Transplantation. 93(10). 1031–1037. 21 indexed citations
15.
Balderramo, Domingo, Jhon Prieto, Andrés Cárdenas, & Miquel Navasa. (2011). Hepatic encephalopathy and post-transplant hyponatremia predict early calcineurin inhibitor-induced neurotoxicity after liver transplantation. Transplant International. 24(8). 812–819. 39 indexed citations
16.
Cervera, Carlos, Domingo Balderramo, B. Suárez, et al.. (2009). Donor mannose-binding lectin gene polymorphisms influence the outcome of liver transplantation. Liver Transplantation. 15(10). 1217–1224. 37 indexed citations
17.
Ávila, Matías A., Carmen Berasain, Elena R. García–Trevijano, et al.. (2000). Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma: A novel role for S-adenosylmethionine. Journal of Hepatology. 32. 209–209. 1 indexed citations
18.
Peña, Andrés de la, J.I. Herrero, Bruno Sangro, et al.. (1998). Liver transplantation in cirrhotic patients over 60 years of age.. PubMed. 90(1). 3–14. 10 indexed citations
19.
Camps, J., et al.. (1992). [Detection of hepatitis B virus DNA in serum by gene amplification in patients with chronic hepatitis B and in patients chronic hepatitis C].. PubMed. 98(2). 49–52. 2 indexed citations
20.
Sangro, Bruno, Óscar Beloqui, I. Herrero, et al.. (1991). Treatment of hepatocellular carcinoma (HCC) with intraarterial combination chemotherapy. Journal of Hepatology. 13. S168–S168. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pietro Solero Breakdown of academic impact, for papers by Michael Sorell Breakdown of academic impact, for papers by Nigel Heaton Breakdown of academic impact, for papers by Dario Tavazzi Breakdown of academic impact, for papers by Harald E. Fischer Breakdown of academic impact, for papers by M Bouvier Breakdown of academic impact, for papers by Norio Itokawa Breakdown of academic impact, for papers by Anne McCune Breakdown of academic impact, for papers by A Musca Breakdown of academic impact, for papers by Faisal Saud Dar
Rankless by CCL
2026